SKP2 and cancer: We found that MCF7CCNE1amplified cells were more sensitive to SKP2 inhibition when compared to parental MCF7 cells (Fig. 6, F and G), corroborating the hypothesis that RBness cancers harbor synthetic lethal targeting opportunities similar to those found in RB1-defective cancers.